CORDIS
EU research results

CORDIS

English EN
Platform foR European Preparedness Against (Re-)emerging Epidemics

Platform foR European Preparedness Against (Re-)emerging Epidemics

Objective

Far from receding, the threats posed by infections with epidemic potential grow ever greater. Although Europe has amongst the best healthcare systems in the world, and also the world’s supreme researchers in this field, we lack co-ordination and linkage between networks that is required to respond fast to new threats. This consortium of consortia will streamline our response, using primary and secondary healthcare to detect cases with pandemic potential and to activate dynamic rapid investigation teams that will deploy shared resources across Europe to mitigate the impact of future pandemics on European health, infrastructure and economic integrity.
If funded, PREPARE will transform Europe’s response to future severe epidemics or pandemics by providing infrastructure, co-ordination and integration of existing clinical research networks, both in community and hospital settings. It represents a new model of collaboration and will provide a one-stop shop for policy makers, public health agencies, regulators and funders of research into pathogens with epidemic potential. It will do this by mounting interepidemic (‘peace time’) patient oriented clinical trials in children and in adults, investigations of the pathogenesis of relevant infectious diseases and facilitate the development of sophisticated state-of-the-art near-patient diagnostics. We will develop pre-emptive solutions to ethical, administrative, regulatory and logistical bottlenecks that prevent a rapid response in the face of new threats. We will provide education and training not only to the members of the network, but also to external opinion leaders, funders and policy makers thereby streamlining our future response. By strengthening and integrating interepidemic research networks, PREPARE will enable the rapid coordinated deployment of Europe’s elite clinical investigators, resulting in a highly effective response to future outbreaks based on solid scientific advances.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITEIT ANTWERPEN

Address

Prinsstraat 13
2000 Antwerpen

Belgium

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 4 119 132

Administrative Contact

Anne Adams (Mrs.)

Participants (27)

Sort alphabetically

Sort by EU Contribution

Expand all

Academisch Medisch Centrum bij de Universiteit van Amsterdam

Netherlands

EU Contribution

€ 2 074 696

CARDIFF UNIVERSITY

United Kingdom

EU Contribution

€ 338 489,60

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

Netherlands

EU Contribution

€ 4 928 038

EUROPEAN SOCIETY OF INTENSIVE CARE MEDECINE

Switzerland

EU Contribution

€ 232 286,40

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 1 200 870

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 988 178

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 4 083 884,75

CAPNETZ STIFTUNG

Germany

EU Contribution

€ 536 500

SERVIZO GALEGO DE SAUDE

Spain

EU Contribution

€ 347 400,40

HLA ET MEDECINE

France

EU Contribution

€ 365 843,20

INSTITUT PASTEUR

France

EU Contribution

€ 295 516,80

SVEUCILISTE U SPLITU

Croatia

EU Contribution

€ 248 037,60

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

EU Contribution

€ 509 639,20

BIOCARTIS NV

Belgium

EU Contribution

€ 470 946,40

BIOMAX INFORMATICS AG

Germany

EU Contribution

€ 365 751,75

JANSSEN INFECTIOUS DISEASES DIAGNOSTICS BVBA

Belgium

EU Contribution

€ 187 880

BIOMERIEUX SA

France

EU Contribution

€ 203 309,50

UNIVERSITAETSKLINIKUM BONN

Germany

EU Contribution

€ 648 300

FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS

Italy

EU Contribution

€ 575 800,40

THE UNIVERSITY OF WESTERN AUSTRALIA

Australia

EUROPEAN RESPIRATORY SOCIETY

Switzerland

EU Contribution

€ 284 840

STICHTING WONCA EUROPE

Netherlands

EU Contribution

€ 60 390

EUROPEAN SCIENTIFIC WORKING GROUP ON INFLUENZA

Belgium

EU Contribution

€ 80 362

ROYAL BROMPTON AND HAREFIELD NATIONAL HEALTH SERVICE TRUST

United Kingdom

EU Contribution

€ 408 683

EUROPEAN SOCIETY CLINICAL MICROBIOLOGY INFECTIOUS DISEASES (EUROPAISCHE GESELLSCHAFT FUR KLINISCHE MIKROBIOLOGIE INFEKTIONSKRANKHEITEN)

Switzerland

EU Contribution

€ 197 600

BERRY CONSULTANTS LLP

United Kingdom

EU Contribution

€ 240 000

JANSSEN PHARMACEUTICA NV

Belgium

Project information

Grant agreement ID: 602525

Status

Closed project

  • Start date

    1 February 2014

  • End date

    31 January 2019

Funded under:

FP7-HEALTH

  • Overall budget:

    € 31 130 188,06

  • EU contribution

    € 23 992 375

Coordinated by:

UNIVERSITEIT ANTWERPEN

Belgium